Covid-19 man­u­fac­tur­ing roundup: WHO let­ter out­lines re­boot of IP shar­ing pro­gram; In­dia backs down on do­mes­ti­cal­ly-pro­duced vac­cine tri­al

While vac­cine short­ages have kept many coun­tries in the midst of the pan­dem­ic, the World Health Or­ga­ni­za­tion is re­boot­ing its IP shar­ing scheme.

The Cos­ta Ri­can pres­i­dent Al­vara­do Que­sa­da and Di­rec­tor Gen­er­al of the WHO Tedros Ad­hanom Ghe­brey­sus re­leased a let­ter Thurs­day call­ing for the re­vamp­ing of the Sol­i­dar­i­ty Call to Ac­tion plan that was out­lined a year ago.

“The sin­gle most im­por­tant pri­or­i­ty of the glob­al com­mu­ni­ty is to stop the COVID-19 pan­dem­ic in its tracks, to halt its rapid trans­mis­sion and re­verse the trend of con­se­quen­tial glob­al dis­tress,” the let­ter says. “We know that this goal is on­ly achiev­able when every­one, every­where can ac­cess the health tech­nolo­gies they need for COVID-19 de­tec­tion, pre­ven­tion, treat­ment and re­sponse.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.